Furthermore, PARP1 activity is required for tumor cell growth in vivo and its targeting potently suppresses tumor cell proliferation, suggesting that PARP1 can be targeted on human prostate cancer to suppress tumor growth (90). Here, PARP1 is linked to prostate cancer.